Summit Therapeutics (SMMT) Tops Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts SMMT Hot Sheet
Join SI Premium – FREE
Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.24), GBP0.04 better than the analyst estimate of (GBP0.28).
For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kronos Worldwide (KRO) Tops Q2 EPS by 17c
- Satellogic Inc (SATL) Misses Q2 EPS by 11c
- Carriage Services (CSV) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
